Molecular Curriculum Authors

Authors

Marilee Means, PhD, SCT(ASCP)

Marilee Means has worked as a staff cytotechnologist and supervisor of the cytology laboratory at the University of Kansas Medical Center in Kansas City, Kansas since 1977.  She has also been involved as a program official for the Cytotechnology Program since 1983.  Currently she is a Clinical Associate Professor serving as full time Program Director of the Cytotechnology Program in the School of Allied Health at the University of Kansas Medical Center.  Pursuing a PhD in Curriculum and Instruction for Allied Health Professions involved writing a dissertation on designing a computer delivered instructional unit for cytotechnology students.  Recently, she has served on the ASC Executive Board, as a member of the Summit on the Future on Cytopathology, as past Chair of the Cytotechnology Programs Review Committee (CPRC), and has been active as Chair of the Program Faculty Seminar.  These interests have converged in serving as the Chair of the Core Curriculum Committee on Molecular Biology.   This Committee wrote the curriculum for this project to assist our programs in introducing new molecular knowledge and methods into the cytotechnology laboratory.

Dr. Means has no disclosures, financial or otherwise, regarding any product or company discussed.


Keisha Brooks, MS, CT, MB(ASCP)

Ms. Brooks earned a BS from the Cytotechnology Program at the University of Tennessee Health Science Center, followed by a MS in Healthcare Administration from Center Michigan University.  She is pursuing an EdD in Educational Leadership at the University of Memphis.  Keisha has worked as a cytotechnologist at Quest Diagnostics and American Esoteric Laboratory.  Currently, she is an Assistant Profession for Clinical Laboratory Sciences at the University of Tennessee Health 3957Science Center.

Ms. Brooks has no disclosures, financial or otherwise, regarding any product or company discussed.


 

Jill L. Caudill, MEd, SCT(ASCP)CM                                                              

Jill L. Caudill is the Program Director for the Cytotechnology Program at the Mayo Clinic in Rochester, Minnesota. She received her undergraduate degree in biology from Butler University in Indianapolis, Indiana. Her Cytotechnology training was completed at Indiana University/Purdue University also in Indianapolis. She has a Master’s degree in Adult Education and has also received her Specialist Certification in Cytotechnology through the ASCP Board of Certification. She has been in the field over 30 years, and held the position of Program Director for the last 20 years.

Ms. Caudill has no disclosures, financial or otherwise, regarding any product or company discussed.


  Sandra Giroux, MS, SCT(ASCP)

Sandra Giroux is the Program Director for the Cytotechnology Program at the Fletcher Allen Health Care in Burlington, Vermont.  She received her undergraduate degree in Medical Laboratory Sciences from Hunter College in New York City. Her Cytotechnology training was completed at the Medical Center Hospital of Vermont. She has a Master’s degree in Administration and has also received her Specialist Certification in Cytotechnology through the ASCP Board of Certification.  Sandra is also a Cytotechnology Fellow Member of the International Academy of Cytology.  She has been in the field over 30 years, and held the position of Program Director for the last 27 years.

Ms. Giroux has no disclosures, financial or otherwise, regarding any product or company discussed


  Stephanie Hamilton, EdD, MB, SCT(ASCP)  

Dr. Stephanie Hamilton is Program Director and Assistant Professor for the Cytotechnology Program at MD Anderson Cancer Center.  She has a Biology degree from Texas A&M University, a Master’s degree in Allied Health Teacher Education and Administration, and a Doctorate in Higher Education Administration, both from the University of Houston.  She completed her certificate in Cytotechnology from The University of Texas Health Science Center/MD Anderson Cancer Center and has over 30 years of experience in the field.  She is Board certified from the American Society of Clinical Pathology (ASCP) in Cytotechnology, Specialist in Cytotechnology, and in Molecular Biology, as well as certification through the International Academy of Cytology.

Dr. Hamilton has no disclosures, financial or otherwise, regarding any product or company discussed.


 

Kara Hansing, BS, SCT(ASCP)CM   

Kara Hansing is the Education Coordinator for the Cytotechnology Program at the Mayo Clinic in Rochester, Minnesota.  She received her Bachelor’s degree in Biology from Carroll College in 2002 and graduated from the Mayo School of Health Sciences Cytotechnology Program in 2003. She received her Specialist Certification in Cytotechnology from the ASCP Board of Certification in 2009. Before taking on her current role working with her former teacher, Jill Caudill, Kara was the Education Specialist for the Cytology Lab at Mayo for almost five years where she was responsible for training newly hired cytotechnologists and retraining current cytotechnologists, and facilitated FISH training for employees, students and residents.

Ms. Hansing has no disclosures, financial or otherwise, regarding any product or company discussed. 


  Timothy L. St. John, BS, CT(ASCP)  
  
Timothy L. St. John is the Manager of Anatomic Pathology at Fletcher Allen Health Care in Burlington, Vermont. In 1987, he received his Bachelor of Science degree in Biology from the University of Maine in Orono, Maine.  His Cytotechnology training was completed at the Medical Center Hospital of Vermont in Burlington, Vermont in 1988.  Tim was promoted into his current position in 2009.  Before that, he was the Supervisor of Cytopathology at Fletcher Allen for over 15 years.

Mr. St. John has no disclosures, financial or otherwise, regarding any product or company discussed.


  Mary Tang, MD  
   
Dr. Mary Tang is the Medical Director for the Cytogenetics and Molecular Diagnostics Laboratories at Fletcher Allen Health Care and Associate Professor of Pathology  and Laboratory Medicine at the University of Vermont in Burlington, Vermont.   She received her medical degree from the University of Vermont and has trained at the Cleveland Clinic, Medical Center Hospital of Vermont and University of Pittsburgh Medical Center.  She has board certification in Anatomic and Clinical Pathology, Chemical Pathology, and Molecular Genetic Pathology.   She has focused on Cytogenetics and Molecular Diagnostic for 10 years.

Dr. Tang has no disclosures, financial or otherwise, regarding any product or company discussed.


 

Amy J. Wendel Spiczka, MS, SCT, MB, HTL(ASCP)CM

Amy J. Wendel Spiczka is Anatomic Pathology Manager at Mayo Clinic, Scottsdale, Arizona and Assistant Professor of Laboratory Medicine & Pathology in the Mayo Clinic College of Medicine. She has served as staff histology technician, cytotechnologist, education supervisor, histology technician program director and cytotechnology program education coordinator. She has also developed molecular pathology training for staff, pathology residents/fellows and pathologists.   Amy holds a Masters of Science degree in professional studies in education.  Ms. Spiczka’s areas of research and education expertise include endocervical glandular lesions, fluorescence in situ hybridization and new professional opportunities for allied health staff in anatomic pathology.

Ms. Spiczka has no disclosures, financial or otherwise, regarding any product or company discussed.